- Home
- MYND vs KRON Comparison
MYND vs KRON Comparison
Compare MYND & KRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYND
- KRON
- Stock Information
- Founded
- MYND 1998
- KRON 2017
- Country
- MYND Cayman Islands
- KRON United States
- Employees
- MYND N/A
- KRON N/A
- Industry
- MYND Other Consumer Services
- KRON Medicinal Chemicals and Botanical Products
- Sector
- MYND Real Estate
- KRON Health Care
- Exchange
- MYND Nasdaq
- KRON Nasdaq
- Market Cap
- MYND 60.3M
- KRON 60.3M
- IPO Year
- MYND 2017
- KRON 2020
- Fundamental
- Price
- MYND $1.58
- KRON $0.85
- Analyst Decision
- MYND
- KRON Buy
- Analyst Count
- MYND 0
- KRON 3
- Target Price
- MYND N/A
- KRON $1.63
- AVG Volume (30 Days)
- MYND 81.3K
- KRON 121.3K
- Earning Date
- MYND 08-29-2024
- KRON 11-13-2024
- Dividend Yield
- MYND N/A
- KRON N/A
- EPS Growth
- MYND N/A
- KRON N/A
- EPS
- MYND N/A
- KRON N/A
- Revenue
- MYND $357,050,000.00
- KRON $9,865,000.00
- Revenue This Year
- MYND N/A
- KRON $52.58
- Revenue Next Year
- MYND N/A
- KRON N/A
- P/E Ratio
- MYND N/A
- KRON N/A
- Revenue Growth
- MYND N/A
- KRON 146.56
- 52 Week Low
- MYND $0.61
- KRON $0.69
- 52 Week High
- MYND $14.20
- KRON $1.60
- Technical
- Relative Strength Index (RSI)
- MYND 60.00
- KRON 40.22
- Support Level
- MYND $1.42
- KRON $0.83
- Resistance Level
- MYND $1.70
- KRON $0.98
- Average True Range (ATR)
- MYND 0.13
- KRON 0.06
- MACD
- MYND 0.01
- KRON -0.01
- Stochastic Oscillator
- MYND 65.81
- KRON 25.00
About MYND Mynd.ai Inc.
Mynd.ai Inc is a company that provides a platform for delivering digital content in K-12 classrooms, giving teachers seamless connectivity to inspire young minds. It features agnostic hardware that integrates across technology providers. Its product line includes a wide range of interactive tools and technologies, with its award-winning interactive displays at the forefront. It also offers interactive software apps such as Screen Share, computing modules, and accessories that meet the needs of customers, including K -12 educators, colleges and universities, small businesses and corporations, government agencies, and more.
About KRON Kronos Bio Inc.
Kronos Bio Inc is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes through a precision medicine plan by targeting dysregulated transcription. The company operates in one business segment, the development of biopharmaceutical products.